Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid for prehospital trauma bleeding
IRCT20140528017891N7Phase 3Completed
- Sponsor
- Tehran Emergency Center
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of tranexamic acid in post-traumatic hemorrhage and Bleeding (2 arms), sponsored by Tehran Emergency Center. Primary endpoints: Blood transfusion or blood product use, Mortality and 1 more. Started Nov 2019; status: completed.
02
Drugs
tranexamic acid
03
Conditions
post-traumatic hemorrhageBleeding
Beyond the preview
Go deeper on IRCT20140528017891N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140528017891N7.